Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 25,542,000 | 24,358,000 | 20,918,000 | 18,274,000 | 16,965,000 |
| Cost of Goods | 14,214,000 | 13,501,000 | 11,470,000 | 9,902,000 | 9,209,000 |
| Gross Profit | 11,328,000 | 10,857,000 | 9,448,000 | 8,372,000 | 7,756,000 |
| Operating Expenses | 6,734,000 | 7,074,000 | 6,488,000 | 5,914,000 | 5,420,000 |
| Operating Income | 4,594,000 | 3,783,000 | 2,960,000 | 2,458,000 | 2,336,000 |
| Interest Expense | 676,000 | 667,000 | 592,000 | 0 | 0 |
| Other Income | 154,000 | 146,000 | 61,000 | -434,000 | -400,000 |
| Pre-tax Income | 4,072,000 | 3,262,000 | 2,429,000 | 2,024,000 | 1,936,000 |
| Income Tax | 374,000 | 324,000 | 201,000 | -1,000 | -44,000 |
| Net Income Continuous | 3,698,000 | 2,938,000 | 2,228,000 | 2,025,000 | 1,980,000 |
| Net Income Discontinuous | N/A | N/A | -3,000 | -3,000 | -5,000 |
| Minority Interests | 2,000 | N/A | N/A | N/A | N/A |
| Net Income | $3,696,000 | $2,938,000 | $2,225,000 | $2,022,000 | $1,975,000 |
| EPS Basic Total Ops | 9.24 | 7.31 | 5.64 | 5.12 | 4.96 |
| EPS Basic Continuous Ops | 9.25 | 7.31 | 5.65 | 5.13 | 4.97 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 9.17 | 7.24 | 5.59 | 5.09 | 4.92 |
| EPS Diluted Continuous Ops | 9.18 | 7.24 | 5.60 | 5.10 | 4.93 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 12.35 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $6,871,000 | $6,050,000 | $4,993,000 | $4,216,000 | $4,024,000 |